The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · Pricing · continued

Price changes over 2025 and 2026, tabulated and dated — does this still hold? posts 151–157

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

VM
v.malinowskiTL219 Apr 2026#151
VS
vial_slopeTL3Regular19 Apr 2026#152

Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers and manufacturers.

16 likes 3mo
NH
n.hartmannTL2 Moderator20 Apr 2026#153
j.iyer, post #73: post #72 answers the question as asked. The question underneath it is different. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live. Go to post

Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These have eligibility restrictions but can save money.

6 likes in reply to #73 3mo
ST
stopper_traceTL2Member21 Apr 2026#154
c.bakker, post #39: Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some proteins; incretin agonist pricing might follow. Go to post

post #153 is right about the mechanism and I think understates the practical bit.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

1 like in reply to #39 3mo
MG
m.guerreroTL2 Moderator22 Apr 2026 · edited#155

Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually obtainable differ.

0 likes 3mo
N
NHuddlestonTL1Member23 Apr 2026#156

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

22 likes 3mo
FY
f.yildizTL2 Moderator24 Apr 2026#157

On post #153 — agreed on the reasoning, with one qualification.

Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing matters.

10 likes 3mo

Suggested topics

TopicParticipantsRepliesViewsActivity
About the Pricing category
List prices, negotiated prices, and cost per milligram compared honestly across formats. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
JMBNHFDTMP+1 5 18k 15mo
Revisiting: List price versus negotiated price versus what you pay
Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
VKBVIABDGR+24 28 50k 12mo
Cost per milligram, computed honestly across formats — the long version
Cost per milligram, computed honestly across formats — the long version Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
BABISAFPCO+111 124 24k 14mo
Cost per milligram, computed honestly across formats
Posting this under the heading it deserves: Cost per milligram, computed honestly across formats Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
BVTDV 2 47k 18mo
Coming back to: Why the cheapest option is often not the cheapest
Why the cheapest option is often not the cheapest — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access outcome, dated, because everything in this…
DADVDBRMMP+21 25 55k 13mo

Related topics — sharing the tags compounding, formulary, cost per milligram

TopicParticipantsRepliesViewsActivity
Revisiting: Reading a denial letter as a specification for your appeal
Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. A coverage question with the paperwork detail…
HAITBBPMN+125 138 9.4k 10mo
Peer-to-peer review: what actually happens on the call
On the subject in the title: Peer-to-peer review: what actually happens on the call Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires.…
NNECPB 2 1.2k 1d
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. A logistics question, since the…
CRDPICCDJB+50 56 780 8mo
Follow-up: Prior authorisation: what the criteria usually require
Prior authorisation: what the criteria usually require — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…
BBFDTAZRA+95 100 9.1k 10h
[2026 update] EU-wide position versus national implementation
On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…
FIANDT 2 54k 19mo